Latest News of IMVT
Is Immunovant, Inc. (IMVT) the Worst Performing Stock to Buy on the Dip?
By Yahoo! Finance |
1 month ago
Despite increased market volatility, experts suggest investing in equities as the market shows signs of economic softness and potential for continued earnings growth. Immunovant, Inc....
Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?
By Yahoo! Finance |
2 months ago
Immunovant's fair value estimate is 19% higher than its analyst price target. Using a Discounted Cash Flow model, the intrinsic value of the company is calculated at US$8.5b, showing a 46% discount to...